More on BAX
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Condensed Consolidated Statements of Income [Abstract] | |
| Net sales | 2.56B |
| Cost of sales | 1.49B |
| Gross margin | 1.07B |
| Marketing and administrative expenses | 726M |
| Research and development expenses | 159M |
| Net interest expense | |
| Other expense, net | 44M |
| Income before income taxes | |
| Income tax expense | 1M |
| Net income | |
| Less: Noncontrolling interests | |
| Net income attributable to Baxter International Inc. (Baxter) | 130M |
| Net income attributable to Baxter per common share | |
| Basic | 0.24 |
| Diluted | 0.24 |
| Weighted-average number of common shares outstanding | |
| Basic | 544M |
| Diluted | 551M |
| Cash dividends declared per common share | 0.13 |
Entities mentioned with bax
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- Third Point LLC | View Related Stories »
- JPMorgan | View Related Stories »
- Citi | View Related Stories »
- Show More...
